---
title: A Prof Chee Khoon Lee
permalink: /atorg-members/scientific-steering-committee/dr-chee-khoon-lee/
variant: markdown
description: ""
third_nav_title: Scientific Steering Committee
---
<img src="/images/ATORG%20Oncology%20Research%20Group/Scientific%20Steering%20Committee/image004_02.jpg" style="width: 150px; float: left; margin-right: 10px;">

<strong>A/Prof Chee Khoon Lee<br>
Consultant Medical Oncologist<br>
Director, Clinical Research Unit (Medical Oncology), St George Hospital<br>
Clinical Lead Research Fellow,<br>
National Health and Medical Research Council (NHMRC) Clinical Trials Centre, The University of Sydney</strong>

Dr. Chee Khoon Lee is a consultant medical oncologist, and a staff specialist at the St George Hospital and the Sutherland Hospital. He obtained his medical degree (with honours) from The University of Sydney in 2000. He completed his clinical fellowship training in internal medicine and medical oncology at St George and Prince of Wales Hospitals, and is a fellow of the Royal Australasian College of Physicians (2009). He has Master degrees in clinical epidemiology (2004), and in biostatistics (2009). He obtained his PhD from the University of Sydney in 2012 for his methodological work in the conduct of clinical trials involving biomarkers for personalising treatment in patients with advanced cancers.

Dr. Leeâ€™s clinical interests are broad ranging with a subspeciality focus on thoracic and gynaecological malignancies. He is the Director of the Clinical Research Unit (Medical Oncology) at St George Hospital. Dr. Lee is principal investigator of a number of academic and pharmaceutical clinical trials conducted at St George Hospital. He actively enrolls patients into clinical studies that investigate novel therapeutic agents in lung, ovarian, and breast cancers.

Dr. Lee also contributes significantly to research and teaching. He also works as a Clinical Lead Research Fellow at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre at the University of Sydney. His research interests include development of more efficient clinical trial designs, and investigate novel statistical approaches to demonstrate the prognostic, predictive and surrogate properties of molecular and other novel biomarkers. He is a chief investigator in a number of NHMRC project grants totaling more than $1.5 million. Dr. Lee serves as a scientific advisory committee member for the Australia and New Zealand Breast Cancer Trials Group (since 2013), project team member of the Cancer Australia Genomic Cancer Clinical Trials Initiative (since 2013) and project team member of the Cancer Molecular Screening and Therapeutics (MoST) study (since 2014). Dr. Lee is a teaching faculty member of the Master of Clinical Trials Research and Masters of Public Health programs at the University of Sydney and the Australia &amp; Asia Pacific Clinical Oncology Research Development Workshop.